|
|
Volumn 41, Issue 2, 2013, Pages 93-107
|
|
Combination therapy with DPP-4 inhibitors and insulin in patients with type 2 diabetes mellitus: what is the evidence?
a
a
not available
*
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADAMANTANE;
ALOGLIPTIN;
ANTIDIABETIC AGENT;
DIPEPTIDE;
DIPEPTIDYL PEPTIDASE IV INHIBITOR;
DRUG DERIVATIVE;
INSULIN;
LINAGLIPTIN;
NITRILE;
PIPERIDINE DERIVATIVE;
PURINE DERIVATIVE;
PYRAZINE DERIVATIVE;
PYRROLIDINE DERIVATIVE;
QUINAZOLINE DERIVATIVE;
SAXAGLIPTIN;
SITAGLIPTIN;
TRIAZOLE DERIVATIVE;
URACIL;
VILDAGLIPTIN;
BODY WEIGHT;
CHRONIC KIDNEY FAILURE;
DIABETES MELLITUS;
DISEASE COURSE;
DRUG COMBINATION;
DRUG EFFECT;
HUMAN;
HYPOGLYCEMIA;
NON INSULIN DEPENDENT DIABETES MELLITUS;
REVIEW;
ADAMANTANE;
BODY WEIGHT;
DIABETES COMPLICATIONS;
DIABETES MELLITUS, TYPE 2;
DIPEPTIDES;
DIPEPTIDYL-PEPTIDASE IV INHIBITORS;
DISEASE PROGRESSION;
DRUG THERAPY, COMBINATION;
HUMANS;
HYPOGLYCEMIA;
HYPOGLYCEMIC AGENTS;
INSULIN;
NITRILES;
PIPERIDINES;
PURINES;
PYRAZINES;
PYRROLIDINES;
QUINAZOLINES;
RENAL INSUFFICIENCY, CHRONIC;
TRIAZOLES;
URACIL;
|
|
EID: 84880557379
PISSN: 21548331
EISSN: None
Source Type: None
DOI: 10.3810/hp.2013.04.1059 Document Type: Review |
|
Times cited : (21)
|
|
References (0)
|
